Skip to main content

Table 1 Main results of the baseline variables

From: Intradialytic neuromuscular electrical stimulation with optional virtual reality distraction improves not only muscle strength and functional capacity but also serum albumin level in haemodialysis patients: a pilot randomized clinical trial

 

NMES group

n = 12

NMES + VR group

n = 9

CO group

n = 11

p value

Age (years)

66.75 ± 9.81

67.50 (64.00–72.25)

66.22 ± 9.11

68.00 (60.50–70.50)

72.00 ± 11.39

68.00 (60.50–70.50)

0.36

Gender (female/male in %)

16.67/83.33

11.11/88.89

27.27/72.73

0.74

Weight (kg)

77.13 ± 22.54

73.75 (57.43–88.48)

71.64 ± 13.61

68.30 (63.10–81.35)

70.86 ± 12.68

70.80 (62.70–76.60)

0.65

Body mass index (kg/m2)

25.69 ± 6.90

24.45 (21.00–28.68)

24.61 ± 2.77

24.10 (23.10–26.45)

24.94 ± 4.08

24.90 (21.30–29.50)

0.88

HD time (months)

60.00

(14.25–93.75)

60.00

(24.00–113.50)

60.00

(30.00–96.00)

0.60

Primary disease of HD

   

0.62

Autoimmune

1

0

1

 

Cancer

0

0

1

 

Diabetic nephropathy

0

1

0

 

Hypertension

0

1

0

 

After heart surgery

0

0

1

 

Haemolytic, uremic syndrome

1

0

0

 

Polycystic kidney disease

1

2

1

 

Due to genetics

0

1

0

 

Unknown

9

4

7

 

Baseline questions

Q1: technical interest

3 (3–4)

4 (1.5–4.5)

4 (2–5)

0.94

Q2: physical status

3 (2–3.8)

3 (2–3.5)

3 (1–5)

0.96

Q3: disability due to HD

3 (2–3)

4 (2–4)

3 (2–4)

0.64

  1. Results expressed as mean (standard deviation) and/or median (interquartile range)
  2. Q1: I am interested in technology and in this respect, I like to be up to date with the latest technology.; Q2: My physical condition affects my everyday life, e.g., out of fear of falling.; Q3: Haemodialysis makes me feel restricted in my physical activity.; Q1-Q3 rated by a 5-likert scale
  3. NMES Neuromuscular electrical stimulation, NMES + VR Neuromuscular electrical stimulation + virtual reality, CO control, HD haemodialysis; Statistical significance: *p < 0.05 comparison between groups